FDA Inspection 1176784 — CoreLink LLC
The FDA completed an inspection of CoreLink LLC on July 27, 2022 in Fenton, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 27, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Fenton, MO (United States)